The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67

Journal of Cellular Biochemistry

Volumn 76, Issue 4, 2000, Pages 596-604

  Wu, Yulian ^a   Luo, Hongyu ^b   Kanaan, Nada ^b   Wu, Jiangping ^b,c,d  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Ki 67; Lactacystin; P27(kip1); p21(cip1); Pancreatic tumor; Proteasome

Indexed keywords

KI 67 ANTIGEN; PROTEASOME; PROTEIN P21; PROTEIN P27;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; ENZYME ACTIVITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM;

ACETYLCYSTEINE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; KI-67 ANTIGEN; MICROSCOPY, FLUORESCENCE; MICROTUBULE-ASSOCIATED PROTEINS; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033968043     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(20000315)76:4<596::AID-JCB8>3.0.CO;2-N     Document Type: Article

References (29)

1. Braun N, Papadopoulos T, Muller-Hermelink HK. 1988. Cell cycle dependent distribution of the proliferation associated Ki-67 antigen in human embryonic lung cells. Virchows Arch Cell Pathol 56:25-33.
2. Bruno S, Darzynkiewicz Z. 1992. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif 25:31-40.
3. d-specific TCR transgenic mice transplanted with allogenic hearts under the cover of a short-term rapamycin treatment. J Immunol 157:4297-4308.
4. Cui, H, Matsui K, Omura S, Schauer SL, Matulka RA, Sonenshein GE, Ju ST. 1997. Proteasome regulation of activation-induced T cell death. Proc Natl Acad Sci USA 94:7515-7520.
5. Deshaies R J, Chau V, Kirschner M. 1995. Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway. EMBO J 14:303-312.
6. Duchrow M, Schluter C, Wohlenberg C, Flad HD, Gerdes J. 1995. Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67. Cell Prolif 29:1-12.
7. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726-731.
8. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. 1984. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715.
9. Gerdes J, Schwab U, Lemke H, Stein H. 1993. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13-20.
10. Imajoh-Ohmi S, Kawaguchi T, Sugiyama S, Tanaka K, Omura S, Kikuchi H. 1995. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem Biophys Res Commun 217: 1070-1077.
11. Jentsch S, Schlender S. 1995. Selective protein degradation: a journey's end within the proteasome. Cell 82:881-884.
12. Labaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. 1997. New functional activities for the p21 family of CKD inhibitors. Genes Dev 11:847-862.
13. Lin L, DeMartino GN, Greene WC. 1998. Cotranslational biogenesis of NF-κB p50 by the 26S proteasome. Cell 92:819-828.
14. Luo H, Chen H, Daloze P, Chang JY, St-Louis G, Wu J. 1992. Inhibition of in vitro immunoglobulin production by rapamycin. Transplantation 53:1071-1076.
15. Orlowski M, Cardozo C, Michaud C. 1993. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 32:1563-1572.
16. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal D, Chau V, Yew PR, Draetta GF, Rolfe M. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
17. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78:773-785.
18. Rechsteiner M, Rogers SW. 1996. PEST sequences and regulation by proteolysis. TIBS 21:267-271.
19. Rock K L, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771.
20. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
21. Schluter C, Duchrow M, Wohlenberg C, Becker MHG, Key G, Flad HD, Gerdes J. 1993. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 123:513-522.
22. Seufert W, Futcher B, Jentsch S. 1995. Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 373:78-81.
23. Shan X, Luo H, Houle B, Wu J. 1994. Regulation of a G protein β2 subunit-related gene during lymphocyte activation. Int Immunol 6:739-749.
24. Tazzari PL, Bontadini A, Gobbi M, Tasi C, Dinota A, Visani G, Michieli MG, Pileri S, Baccarani M, Tura S. 1990. Comparison of the DNA content, bromodeoxyuridine incorporation and Ki-67 antigen expression in human acute myeloid leukemia. Leuk Lymphoma 3:45-51.
25. kip1 is instigated by Jabl. Nature 398:160-164.
26. Treier M, Staszewski LM, Bohmann D. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78:787-798.
27. kip1. EMBO J 16:5334-5344.
28. Wang X, Luo H, Chen H, Duguid W, Wu J. 1998. Role of proteasomes in T cell activation and proliferation. J Immunol 160:788-801.
29. Cdc28-mediated control of Cln3 cyclin degradation. Mol Cell Biol 15:731-741.